Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.88%
1,100.61
-9.73
-0.88%
1,110.341,110.371,117.241,097.84
SIXC
Communications
SIXC
Communications
SIXC
-1.33%
612.30
-8.24
-1.33%
620.54620.54622.67611.42
SIXE
Energy
SIXE
Energy
SIXE
+1.40%
1,175.46
+16.26
+1.40%
1,159.201,160.591,177.621,156.21
SIXI
Industrials
SIXI
Industrials
SIXI
-1.39%
1,729.12
-24.32
-1.39%
1,753.441,749.081,762.011,724.74
SIXM
Financials
SIXM
Financials
SIXM
-0.63%
644.73
-4.07
-0.63%
648.80649.58655.73643.68
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
827.09
-5.40
-0.65%
832.49832.07833.09826.15
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.98%
214.82
-4.34
-1.98%
219.16219.16219.19214.82
SIXT
Technology
SIXT
Technology
SIXT
+0.06%
3,115.17
+1.81
+0.06%
3,113.363,120.793,143.643,105.16
SIXU
Utilities
SIXU
Utilities
SIXU
-1.75%
910.43
-16.24
-1.75%
926.67927.99930.54910.08
SIXV
Health care
SIXV
Health care
SIXV
-1.01%
1,474.50
-15.11
-1.01%
1,489.611,499.051,499.051,474.35
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,405.87
-17.39
-0.72%
2,423.262,438.162,443.462,399.83
AVTX:NASDAQ
Avalo Therapeutics Inc
$14.29
-2.52%
(-0.37) 1D
$14.29
0.00% (0.00)
After hours
Closed: Apr 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVTX...
Open
$14.75
High
$14.75
Low
$14.12
Mkt. cap
381.75M
Avg. vol.
848.76K
Volume
0.00
52-wk high
$20.72
52-wk low
$3.39
EPS
-$5.84
Beta
0.93
Shares outstanding
22.79M
No. of employees
33
News stories
From sources across the web
About Avalo Therapeutics Inc
CEO-
Employees33
Founded2011
HeadquartersRockville, Pennsylvania, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
59.00K
Cost of goods sold
5.91M
10.66M
9.99M
8.78M
Cost of revenue
5.91M
10.66M
9.99M
8.78M
Research and development expenses
3.21M
3.41M
3.63M
4.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.55M
5.24M
5.58M
6.53M
Operating expense
8.76M
8.66M
9.21M
11.02M
Total operating expenses
14.67M
19.32M
19.20M
19.80M
Operating income
-14.67M
-19.32M
-19.20M
-19.74M
Other non operating income
380.00K
-2.54M
-12.53M
5.17M
EBT including unusual items
-13.14M
-20.75M
-30.61M
-13.59M
EBT excluding unusual items
-13.14M
-20.75M
-30.61M
-13.59M
Income tax expense
8.00K
16.00K
11.00K
130.00K
Effective tax rate
-0.06%
-0.08%
-0.04%
-0.96%
Other operating expenses
-
-
-
-
Net income
-13.15M
-20.76M
-30.62M
-13.72M
Net profit margin
-
-
-
-23,254.24%
Earnings per share
-1.25
-1.92
-2.19
-0.37
Interest and investment income
1.15M
1.10M
1.12M
984.00K
Interest expense
-
-
-
-
Net interest expenses
1.15M
1.10M
1.12M
984.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.53M
-19.18M
-19.14M
-19.73M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more